Skip to main content

Peer Review reports

From: Safety and adherence of bictegravir/emtricitabine/tenofovir alafenamide for HIV post-exposure prophylaxis among adults in Guiyang China: a prospective cohort study

Original Submission
23 Nov 2023 Submitted Original manuscript
10 Dec 2023 Reviewed Reviewer Report
19 Jan 2024 Reviewed Reviewer Report
8 Feb 2024 Author responded Author comments - Hai Long
29 Mar 2024 Author responded Author comments - Hai Long
Resubmission - Version 2
8 Feb 2024 Submitted Manuscript version 2
3 Apr 2024 Author responded Author comments - Hai Long
Resubmission - Version 3
3 Apr 2024 Submitted Manuscript version 3
6 Apr 2024 Author responded Author comments - Hai Long
Resubmission - Version 4
6 Apr 2024 Submitted Manuscript version 4
11 May 2024 Author responded Author comments - Hai Long
Resubmission - Version 5
11 May 2024 Submitted Manuscript version 5
Publishing
15 May 2024 Editorially accepted
6 Jun 2024 Article published 10.1186/s12879-024-09407-9

You can find further information about peer review here.

Back to article page